Brain chemistry study explores attention in aging
NCT ID NCT04756232
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at how a drug that blocks a brain chemical called acetylcholine affects attention in older adults with mild memory concerns. Nineteen participants aged 55 and older took either the drug or a placebo and had their brain activity measured with EEG. The goal was to understand if the brain works harder to maintain attention in people with early memory changes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Mecamylamine
- What this could lead to
- If successful, this could help explain why some older adults have trouble focusing, pointing toward future ways to support attention.
- What could go wrong
- This is a very early, small study with only 19 participants. It is designed to measure brain activity, not to treat or cure any condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBJECTIVE COGNITIVE DECLINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37212, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could chatting with AI keep aging brains sharp?
- Simple blood test may replace spinal taps for Alzheimer's diagnosis
- Aggressive blood pressure control may fight Alzheimer's in the brain
- Can a friendly video chat lift depression in older adults?
- AI could spot Alzheimer's years before symptoms worsen
- Brain's secret weapon against memory decline revealed?